[AHA] Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States |
|
This post will be closed automatically in 2026-10-21 17:57
Best Answer
2026-10-18
|
| |
20
[Supplementary]Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study
50
Integrated Assessment of Computational Coronary Physiology From a Single Angiographic View in Patients Undergoing TAVI
30
[Supplementary]Real-World Multiple Comparison of Transcatheter Aortic Valves: Insights From the Multicenter OBSERVANT II Study
20
Contribution ofAPOEGenetic Variants to Dyslipidemia
10
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial
